← Leaderboards
Christopher Fisher
Nanovir, Llc.
$7,692,828
Attributed
$7,692,828
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,692,828 · 4
By mechanism
R42$5,942,780 · 2
R41$1,750,048 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chemical Synthesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$156,891,547
- David H Walker · University Of Texas Medical Br Galveston$61,066,312
- Jay D Keasling · University Of California-Berkeley$45,089,571
- Marc A Hillmyer · University Of Minnesota-Twin Cities$43,647,280
- Huw M Davies · Suny At Buffalo$42,517,196
- Harry B Gray · California Institute Of Technology$40,481,419
Research focus
Chemical SynthesisAntiviral AgentsSafetyVirusIndexingCancer EtiologyOperative Surgical ProceduresHuman Papillomavirus 16Toxic EffectUptakeDesignBaseCellsToxicologyIn VitroPre-ClinicalIn VivoMalignant Neoplasm Of Cervix UteriWomanHuman Papilloma Virus InfectionDrug KineticsHuman Papilloma Virus VaccineCervicalAmes Assay
Grant awards (10)
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa$1,000,000
R42 · FY2012 · AI · contact PI
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa$1,000,000
R42 · FY2011 · AI · contact PI
Pre-clinical Development of a Broad Spectrum Antiviral Compound to Treat Human Pa$1,000,000
R42 · FY2010 · AI · contact PI
Pre-Clinical HPV16 Antiviral Compound Development$965,617
R42 · FY2010 · AI · contact PI
Pre-Clinical HPV16 Antiviral Compound Development$977,163
R42 · FY2009 · AI · contact PI
Pre-Clinical HPV16 Antiviral Compound Development$1,000,000
R42 · FY2008 · AI · contact PI
Antiviral Compounds that Target HPV18 DNA$498,425
R41 · FY2008 · AI · contact PI
Antiviral Compounds that Target HPV18 DNA$480,768
R41 · FY2007 · AI · contact PI
Antiviral Compounds for Human Papillomavirus 16$388,487
R41 · FY2005 · AI
Antiviral Compounds for Human Papillomavirus 16$382,368
R41 · FY2004 · AI